Execution RiskAnalyst warns that if the de‑levering and monetization plan is not executed as modelled, management may need to alter the dividend or other priorities, posing downside risk to the stock.
Health And Digital Growth ChallengesAnalyst indicates that TELUS Health and digital businesses remain in a proof‑of‑concept phase with only modest revenue gains, keeping doubts about near‑term profitability improvements.
Leadership Transition UncertaintyAnalyst points out that the announced CEO retirement and incoming leadership create uncertainty around capital allocation decisions and dividend clarity, which is likely to increase share volatility.